Schacter LP - Search Results

1

Effects of therapy with didanosine on hematologic parameters in patients with advanced human immunodeficiency virus disease.

Schacter LP, Rozencweig M, Beltangady M, Allan JD, Canetta R, Cooley TP, Dolin R, Kelley S, Lambert J, Liebman HA, et al. Schacter LP, et al. Blood. 1992 Dec 15;80(12):2969-76. Blood. 1992. PMID: 1467512 Free article. Clinical Trial.

2

Overview of phase I trials of 2',3'-dideoxyinosine (ddI) conducted on adult patients.

Rozencweig M, McLaren C, Beltangady M, Ritter J, Canetta R, Schacter L, Kelley S, Nicaise C, Smaldone L, Dunkle L, et al. Rozencweig M, et al. Rev Infect Dis. 1990 Jul-Aug;12 Suppl 5:S570-5. doi: 10.1093/clinids/12.supplement_5.s570. Rev Infect Dis. 1990. PMID: 2166965 Clinical Trial.

3

Megestrol acetate: clinical experience.

Schacter L, Rozencweig M, Canetta R, Kelley S, Nicaise C, Smaldone L. Schacter L, et al. Cancer Treat Rev. 1989 Mar;16(1):49-63. doi: 10.1016/0305-7372(89)90004-2. Cancer Treat Rev. 1989. PMID: 2471590 Review.

4

Overview of hormonal therapy in advanced breast cancer.

Schacter LP, Rozencweig M, Canetta R, Kelley S, Nicaise C, Smaldone L. Schacter LP, et al. Semin Oncol. 1990 Dec;17(6 Suppl 9):38-46. Semin Oncol. 1990. PMID: 2148026

5

Drug discovery and development in the pharmaceutical industry.

Schacter LP, Anderson C, Canetta RM, Kelley S, Nicaise C, Onetto N, Rozencweig M, Smaldone L, Winograd B. Schacter LP, et al. Semin Oncol. 1992 Dec;19(6):613-21. Semin Oncol. 1992. PMID: 1462163 Review.

6

Humoral factors in aplastic anemia: relationship of liver dysfunction to lack of serum stimulation of bone marrow growth in vitro.

Karp JE, Schacter LP, Burke PJ. Karp JE, et al. Among authors: schacter lp. Blood. 1978 Mar;51(3):397-414. Blood. 1978. PMID: 623906 Free article. No abstract available.

7

Nicotinamide adenine dinucleotide (NAD) stimulation of DNA synthesis by human bone marrow cells.

Schacter LP, Burke PJ. Schacter LP, et al. Biochem Biophys Res Commun. 1978 Feb 14;80(3):504-10. doi: 10.1016/0006-291x(78)91597-8. Biochem Biophys Res Commun. 1978. PMID: 24445 No abstract available.

8

Phase I and pharmacokinetic study of etoposide phosphate by protracted venous infusion in patients with advanced cancer.

Soni N, Meropol NJ, Pendyala L, Noel D, Schacter LP, Gunton KE, Creaven PJ. Soni N, et al. Among authors: schacter lp. J Clin Oncol. 1997 Feb;15(2):766-72. doi: 10.1200/JCO.1997.15.2.766. J Clin Oncol. 1997. PMID: 9053503 Clinical Trial.

9

Phase I study of high-dose etoposide phosphate in man.

Fields SZ, Budman DR, Young RR, Kreis W, Ingram R, Schulman P, Cherny RC, Wright J, Behr J, Snow C, Schacter LP. Fields SZ, et al. Among authors: schacter lp. Bone Marrow Transplant. 1996 Nov;18(5):851-6. Bone Marrow Transplant. 1996. PMID: 8932836 Clinical Trial.

10

Phase II study of elsamitrucin (BMY-28090) for the treatment of patients with refractory/relapsed non-Hodgkin's lymphoma.

Allen SL, Schacter LP, Lichtman SM, Bukowski R, Fusco D, Hensley M, O'Dwyer P, Mittelman A, Rosenbloom B, Huybensz S. Allen SL, et al. Among authors: schacter lp. Invest New Drugs. 1996;14(2):213-7. doi: 10.1007/BF00210793. Invest New Drugs. 1996. PMID: 8913843 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

30 results

Search Page

Filters